Single Ascending and Multiple Ascending Dose Study of LCA-0061

NCT07701954 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Disease
Peanut Allergies

Interventions

DRUG: LCA-0061
DRUG: Placebo

Sponsor

Lycia Therapeutics, Inc.